Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, January 4, 2013

Medistem Inc. Annual Letter to Shareholders

The clinical trial comprises three escalating doses of ERC with cohorts of 20 patients per dose.

http://www.marketwire.com/press-release/medistem-inc-annual-letter-to-shareholders-pinksheets-meds-1742322.htm
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts